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ABSTRACT : Nuclear DNA patterns were analyzed in the 33 patients with primary 
hepatocellular carcinoma on the basis of clinicopathologic standpoint. It is concluded 
that biologic behavior of hepatocellular cancer cells in patients with DNA aneuploidy 
pattern displayed highly malignant potential, indicating severe atypism, rapid growth of 
rupturing, the presence of cancer invasion into the wall of portal vein and distant 
metastasis. Furthermore, the survival time in patients with DNA aneuploidy pattern in 
hepatocellular carcinoma was shorter than that in patients with diploidy one.
       INTRODUCTION 
 According to advance in diagnostic tech-
niques, echosonography is now prevalent in 
clinical use to detect the tumor mass in the liver. 
Early excision is recommended to improve its 
prognosis. However, early detection is not 
enough for aggressive tumors. The goal of 
satisfactory results requires combined adjuvant 
therapy with potent chemotherapy for preven-
tion of recurrent or metastatic tumor growth. 
 On the other hand, there is nothing to exactly 
assess and compare with the degree of tumor 
malignancy and to expect as to whether or not 
metastasis and/or recurrence appear sooner or 
later. 
 The aim of this study is to clarify the validity 
to assess the malignant potential of carcinoma 
of the liver by means of measurement of cellular 
DNA and RNA in comparison with clinic-
opathologic factors.
   MATERIALS AND METHODS 
 Thirty-three patients with primary hepato-
cellular carcinomas were eligible for this study 
in clinicopathologic and nuclear DNA analysis. 
The ratio of men and women was 28:5. 
According to the disease stages, seven were in 
Stage I, 12 in Stage II, 11 in Stage III and 3 in 
Stage IV. For the measurement of nuclear DNA 
and RNA content, paraffin-embedded materials 
were prepared. These were sliced at 30,um 
sections, dewaxed by xylene, rehydrated by 
using 100%, 95%, 70%, and 50% ethanol and 
washed in distilled water. Moreover, these were 
immersed into trypsincitrate buffer and 
incubated overnight at 37°C. Thereafter, these 
were sequentially moved to stain in the order 
of Solution A (trypsin), Solution B (trypsin 
inhibitor, RNase A), Solution C (speramine 
tetrahydrochorolide propidium iodide). Finally 
fluorescence measurement by using FACS IV 
was made to analyse the nuclear DNA and RNA 
content. The DNA index was calculated as the
following fomula : Peak channel No of cancer 
cells/Peak chennel No of normal cells.
          RESULTS 
 The result of nuclear DNA and RNA was 
divided into the two categories, diploidy (DI 0.9-
1.1) and aneuploidy (DI<1.1) respectively. 
Seventy percent of the patients were shown 
aneuploidy as shown in Table 1. There was no 
difference in distribution of diploidy and 
aneuploidy between both sexes. In advanced 
disease of stage IV, aneuploidy was dominant 
rather than diploidy despite a few cases of stage 
IV. 
 Fig. 1 showed distribution of DNA index. 
Most distributed in the area from 1.0 to 2.3, 
although some were in Dl of 2.5 to 2.9. 
Relationship between tumor sizes and DNA 
patterns was shown in Table 2. The more the 
tumor sizes increase, the higher the incidence 
of aneuploidy has become step by step. It was 
more likely that the tumors without 
capsula-formation indicated aneuploid pattern 
of nuclear DNA rather than diploid one.
    Table 2. 'Tumor sizes and ploidy 
  Size (cm) Diploidy Aneuploidy                (%) (%) 
   2 8 34(37) 5(63) 
2- 5 12 4(33) 8(67) 
5-10 8 2(25) 6(75) 
10- 5 1(20) 4(80) 
        33 10(30) 23(70)
  Table 3. Capsular invasion and ploidy 
                 Diploiy Aneuploidy 
               (%) (%) 
  fc (-) 5 2(40) 3(60) 
   (+) 28 8(29) 20(71) 
fc-inf (-) 11 5(45) 6(55) 
   (+) 22 5(23) 17 (77) 
        33 10(30) 23(70)
  Table 4. Growth modes and ploidy 
                Diploiy Aneuploidy 
             (%) (%) 
eg 29 8(28) 21(72) 
ig 4 2(50) 2(50) 
       33 10(70) 23(70)
Fig. 1. Distribution of DNA Inde),
Table 1. Disease stage and DNA pattern in 
        patients with hepatocellular carcinomas 
              n Diploidy Aneuploidy                   (%) (%) 
Age (mean) 54.7±10.4 54.1±8.3 55.0±11.3 
Sex M 28 9(32) 19( 68) 
Sex F 5 1(20) 4 ( 80) 
Stage 1 7 2(29) 5 ( 71) 
     H 12 4(33) 8 ( 67) 
    III 11 4(40) 7 ( 60) 
    IV 3 0 ( 0) 3(100) 
Total 33 10(30) 23( 70)
However, the finding of capsular infiltration of 
the tumor is more definitively recognized in 
cases of displaying aneuploid patterns than 
diploid one as shown in Table 3. As for the 
growth modality of the tumor as shown in Table 
4, the majority cases showed a mode of eg, 
demonstrating aneuploid pattern of nuclear 
DNA except for 4 cases with ig of growth 
modality, although the mode of ig showed 
aneuploidy pattern in half. 
 As for cellular atypism according to 
Edmondson' classification. Severe Edmondson 
III and IV was more frequently seen in patients 
with aneuploid pattern of cellular DNA than 
diploid one as shown in Table 5. In view of 
portal vein invasion, the patients with aneuploid 
were susceptible to portal vein invasion 
regardless of the degree of cancer invasion into 
the wall of the portal vein which was 
represented as vpl-3 as shown in Table 6. From 
the standpoint of hepatic metastasis, there was 
no tendency that hepatic metastasis increases 
in patients with DNA aneuploid pattern rather
    Table 5. Cellular atypism and ploidy 
                     Diploiy Aneuploidy
                  (%) (%) 
Edmondson I , II 23 8(32) 15(68) 
         III, N 10 2(20) 8(80) 
              33 10(30) 23(70)
   Table 6. Portal invasion and ploin 
                Diploiy Aneuploidy 
              (%) (%) 
vp 0 16 6(38) 10( 62) 
  1 8 1(12) 7 ( 88) 
  2 8 3(37) 5 ( 63) 
  3 1 0 ( 0) 1(100) 
       33 10(30) 23( 70)
  Table 7. Hepatic metastasis and ploidy 
                  Diploiy Aneuploidy
               (%) (%)
im 0 24 8(33) 16( 67) 
  1 7 2(29) 5 ( 71) 
  2,3 2 0 ( 0) 2(100) 
        33 10(30) 23( 70)
Table 8. Relationship between the presence of 
        rupture or distant metastases and ploiy
                   Diploiy Aneuploidy 
                (%) (%)
rupture 4 0(0) 4(100) 
distant 
metastasis 3 0 (0) 3(100)
Fig. 2. Comparison of Survival Rate between 
      Diploid and Aneuploid in Curative Cass
than in those with diploid pattern as shown in 
Table 7.
 In this series, we encountered 4 patients with 
rapid growth of rupture and 3 patients with 
distant metastasis. 
 Patient had an aneuploid pattern of nuclear 
DNA as shown in Table 8, indicating that 
aneuploid pattern implied highly clinical 
malignant potential. The survival time between 
patients with diploidy and aneuploidy patterns 
was compared. Fig. 2 showed that survival time 
in patients with diploid was longer than that 
in patients with aneuploid in analysis of DNA 
patterns.
         DISCUSSION 
 It is common that until recently the degrees 
of malignancy for cancer cells have been 
evaluated by Edmondoson's histologic classi-
fication and/or mitotic index' >2 . However it is 
difficult to assess how malignant cancer cells 
behave biologically. Few reports can be found 
regarding assessment of malignancy for hepatic 
cell carcinoma by analysis of DNA ploidy 
pattern which closely relates to the grade of 
malignancy of cancer cells and prognosis. Many 
reports clarify that DNA ploidy patterns closely 
relate to biologic malignancy of cancer cells and 
are suggestive of its prognosis of tumor-bearing 
host with respect to esophageal cancer3), breast 
cancer 4)5)6) and colon cancer'). 
 In conclusion, aneuploidy pattern of DNA in 
carcinoma of hepatocellular carcinoma was in 
accordance with the severity of cellular atypism 
and portal vein invasion and also suggestive of 
biologic behavior of highly malignant potential 
such as rupturing and distant metastasis. 
Moreover, the survival time in patients with 
DNA aneuploidy pattern was apparently shorter 
than that in patients with DNA ploidy one. The 
longevity of survival time for patients with 
hepatocellular carcinoma may be anticipated by 
analysis of DNA pattern and meticulous 
postoperative cares should be managed by using 
potent anticancer drugs, aiming at improvement 
of surgical outcome.
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